Factors related to prevalence, persistence, and incidence of depressive symptoms in mild cognitive impairment: vascular depression construct
Objective Depression is prevalent among elders with cognitive impairment. Cerebral white matter hyperintensities (WMH) have consistently been implicated in late‐life depression and in cognitive impairment. This study aims to clarify the factors related to prevalence, persistence, and new onset of de...
Gespeichert in:
Veröffentlicht in: | International journal of geriatric psychiatry 2016-07, Vol.31 (7), p.818-826 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective
Depression is prevalent among elders with cognitive impairment. Cerebral white matter hyperintensities (WMH) have consistently been implicated in late‐life depression and in cognitive impairment. This study aims to clarify the factors related to prevalence, persistence, and new onset of depressive symptoms in subjects with mild cognitive impairment (MCI).
Methods
As part of a multicenter prospective study, the Clinical Research Center for Dementia of South Korea (CREDOS) Study, we enrolled 590 subjects diagnosed with MCI and with no prior history of depression. Depressive symptoms were assessed by the Korean version of the Geriatric Depression Scale short form (SGDS‐K) at baseline and at follow‐up visits. Brain magnetic resonance imaging was performed at baseline to quantify WMH using a visual rating scale.
Results
The baseline prevalence of clinically significant depressive symptoms (SGDS‐K ≥5) was 51.4%, and this feature was associated with younger age, lower educational achievement, and higher Clinical Dementia Rating Sum of Boxes (CDR‐SB) scores. Persistence of depressive symptoms across the study period was significantly associated with baseline CDR‐SB and depression scores. New onset of depression (SGDS‐K ≥8; incidence 15.7%) among subjects free of depressive symptoms (SGDS‐K |
---|---|
ISSN: | 0885-6230 1099-1166 |
DOI: | 10.1002/gps.4400 |